$2.61 2.8%
ELDN Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Eledon Pharmaceuticals

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.

Eledon Pharmaceuticals
Price $2.61
Target Price Sign up
Volume 53,780
Market Cap $99M
Year Range $1.12 - $3.12
Dividend Yield 0%
Revenue per Employee $0
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2403.5M-3.5M-10M-11M-0.340
Q4 '2303.3M-3.3M-9.6M-10M-0.290
Q3 '2303.3M-3.3M-10M-11M-0.350
Q2 '2303.2M-3.2M-9.6M-10M-0.400
Q1 '2303M-3M-11M-11M-0.750

Insider Transactions View All

BIOTECHNOLOGY VALUE FUND L P filed to buy 220,460 shares at $0.
May 13 '24
BIOTECHNOLOGY VALUE FUND L P filed to buy 232,068 shares at $0.
May 13 '24
BIOTECHNOLOGY VALUE FUND L P filed to buy 2,633,679 shares at $0.
May 13 '24
BIOTECHNOLOGY VALUE FUND L P filed to buy 3,361,803 shares at $0.
May 13 '24
BIOTECHNOLOGY VALUE FUND L P filed to buy 2,526,238 shares at $0.
May 13 '24

What is the Market Cap of Eledon Pharmaceuticals?

The Market Cap of Eledon Pharmaceuticals is $99M.

How Many People Work at Eledon Pharmaceuticals?

As of our latest update, Eledon Pharmaceuticals employed approximately 17 people worldwide. However, it's important to note that Eledon Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Eledon Pharmaceuticals' revenue per employee?

$0. To calculate Eledon Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Eledon Pharmaceuticals?

Currently, the price of one share of Eledon Pharmaceuticals stock is $2.61.

How can I analyze the ELDN stock price chart for investment decisions?

The ELDN stock price chart above provides a comprehensive visual representation of Eledon Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Eledon Pharmaceuticals shares. Our platform offers an up-to-date ELDN stock price chart, along with technical data analysis and alternative data insights.

Does ELDN offer dividends to its shareholders?

As of our latest update, Eledon Pharmaceuticals (ELDN) does not offer dividends to its shareholders. Investors interested in Eledon Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Eledon Pharmaceuticals?

Some of the similar stocks of Eledon Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.